News

Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas
23andMe study links genetics to GLP-1 weight loss outcomes and side effects
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Life Biosciences raises $80M to advance gene therapy for optic neuropathies
read more
Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain
Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Allucent adds strategy leaders to expand therapeutic expertise
read more
Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development
Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform
read more
Clinical & Regulatory,Digital & Data,Opinion & Events
Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption
read more
Biotech & Pharma Business,Pharmaceuticals and therapeutics
Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
read more
Biotech & Pharma Business,Pharmaceuticals and therapeutics
Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
read more
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
read more
Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas
Aravax adds allergy specialists to board as peanut therapy advances
read more
Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease
read more
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas
Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal
read more
Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program
read more
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism
read more

23andMe study links genetics to GLP-1 weight loss outcomes and side effects

Life Biosciences raises $80M to advance gene therapy for optic neuropathies

Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

Allucent adds strategy leaders to expand therapeutic expertise

Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform

Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

Genmab appoints Margarida Duarte as general manager for Europe and emerging markets

Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America

Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline

Aravax adds allergy specialists to board as peanut therapy advances

AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program

City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism

main menu

recent posts

Trelleborg gains ISO certification for Costa Rica medtech plant

Merck launches bio-based HPLC solvents for pharma labs

Alto starts Phase 2b ALTO-207 trial in treatment-resistant depression

get connected